Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Biotechnology and Bioengineering|February 26, 2011
Mass spectrometry to describe product and contaminant adsorption properties for bioprocess developmentAlex Berrill, Sa V Ho, Daniel G BracewellBiotechnology Progress|September 22, 2009
Ultra scale-down approaches for clarification of mammalian cell culture broths in disc-stack centrifugesFerhana Zaman, Corey M Allan, Sa V HoBiotechnology and Bioengineering|July 19, 2012
Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertaintyJames Pollock, Sa V Ho, Suzanne S FaridBiotechnology Progress|December 30, 2009
Product and contaminant measurement in bioprocess development by SELDI-MSAlex Berrill, Sa V Ho, Daniel G BracewellBiotechnology Progress|March 8, 2008
Ultra scale-down to define and improve the relationship between flocculation and disc-stack centrifugationAlex Berrill, Sa V Ho, Daniel G BracewellBiotechnology Progress|May 9, 2017
Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufactureJames Pollock, Jon Coffman, Sa V Ho, et al.Journal of Chromatography. A|July 16, 2008
Use of cyclohexanedimethanol as a nonflammable organic solvent for industrial scale reversed phase chromatographyAlan K Hunter, Sydney D Hoeltzli, Gary V Johnson, et al.Journal of Chromatography. A|March 5, 2013
Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufactureJames Pollock, Glen Bolton, Jon Coffman, et al.International Journal of Pharmaceutics|June 26, 2013
N-terminal mono-PEGylation of growth hormone antagonist: correlation of PEG size and pharmacodynamic behaviorLing Wu, Sa V Ho, Wei Wang, et al.Molecular Pharmaceutics|June 6, 2012
A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profilesYi Wei, Yuxia Wang, Aijun Kang, et al.Pageof 2